Use of antihypertensive drugs by Medicare enrollees: Does type of drug coverage matter?

被引:41
作者
Adams, AS
Soumerai, SB
Ross-Degnan, D
机构
[1] Drug Policy Research Group, Department of Ambulatory Care, Harvard Medical School, Boston, MA
关键词
D O I
10.1377/hlthaff.20.1.276
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Research has demonstrated that Medicare beneficiaries with drug coverage consume more clinically essential drugs. However, generosity of coverage varies considerably across beneficiaries. This study examines the association between types of drug coverage and the consumption and cost per tablet of essential antihypertensive medications among beneficiaries with hypertension. The findings indicate that while both state- and employer-sponsored drug coverage are associated with greater consumption of antihypertensive drugs and lower out-of-pocket costs per tablet, private supplemental coverage is not associated with greater use and is associated with only slightly lower out-of-pocket costs than among noncovered beneficiaries.
引用
收藏
页码:276 / 286
页数:11
相关论文
共 24 条
[11]  
*NIH, 1997, NIH PUB
[12]  
Poisal JA, 1999, HEALTH CARE FINANC R, V20, P15
[13]   The financial burden of prescription drug use among elderly persons [J].
Rogowski, J ;
Lillard, LA ;
Kington, R .
GERONTOLOGIST, 1997, 37 (04) :475-482
[14]   Estimating causal effects from large data sets using propensity scores [J].
Rubin, DB .
ANNALS OF INTERNAL MEDICINE, 1997, 127 (08) :757-763
[15]   COMPLIANCE IN THE TREATMENT OF HYPERTENSION - A NEED FOR ACTION [J].
SANSONFISHER, RW ;
CLOVER, K .
AMERICAN JOURNAL OF HYPERTENSION, 1995, 8 (10) :S82-S88
[16]   EFFECTS OF MEDICAID DRUG-PAYMENT LIMITS ON ADMISSION TO HOSPITALS AND NURSING-HOMES [J].
SOUMERAI, SB ;
ROSSDEGNAN, D ;
AVORN, J ;
MCLAUGHLIN, TJ ;
CHOODNOVSKIY, I .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (15) :1072-1077
[17]   EFFECTS OF LIMITING MEDICAID DRUG-REIMBURSEMENT BENEFITS ON THE USE OF PSYCHOTROPIC AGENTS AND ACUTE MENTAL-HEALTH-SERVICES BY PATIENTS WITH SCHIZOPHRENIA [J].
SOUMERAI, SB ;
MCLAUGHLIN, TJ ;
ROSSDEGNAN, D ;
CASTERIS, CS ;
BOLLINI, P .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (10) :650-655
[18]   Inadequate prescription-drug coverage for Medicare enrollees - A call to action [J].
Soumerai, SB ;
Ross-Degnan, D .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (09) :722-728
[19]   PAYMENT RESTRICTIONS FOR PRESCRIPTION DRUGS UNDER MEDICAID - EFFECTS ON THERAPY, COST, AND EQUITY [J].
SOUMERAI, SB ;
AVORN, J ;
ROSSDEGNAN, D ;
GORTMAKER, S .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (09) :550-556
[20]   EXPERIENCE OF STATE DRUG BENEFIT PROGRAMS [J].
SOUMERAI, SB ;
ROSSDEGNAN, D .
HEALTH AFFAIRS, 1990, 9 (03) :36-54